Rice Hall James & Associates’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,296
Closed -$2.9M 322
2021
Q4
$2.9M Sell
55,296
-687
-1% -$37.3K 0.1% 181
2021
Q3
$3.35M Sell
55,983
-602
-1% -$37.1K 0.12% 128
2021
Q2
$3.83M Sell
56,585
-18,174
-24% -$1.24M 0.14% 114
2021
Q1
$4.9M Sell
74,759
-1,001
-1% -$60K 0.16% 114
2020
Q4
$4.27M Sell
75,760
-1,622
-2% -$79.8K 0.15% 113
2020
Q3
$3.76M Sell
77,382
-45,083
-37% -$2.43M 0.15% 113
2020
Q2
$6.82M Sell
122,465
-6,659
-5% -$385K 0.29% 96
2020
Q1
$6.54M Sell
129,124
-165,205
-56% -$11.1M 0.37% 80
2019
Q4
$22.8M Sell
294,329
-4,806
-2% -$339K 0.77% 38
2019
Q3
$19M Buy
299,135
+53,616
+22% +$3.35M 0.68% 50
2019
Q2
$14.4M Buy
245,519
+24,340
+11% +$1.44M 0.48% 81
2019
Q1
$12.6M Sell
221,179
-115,492
-34% -$6.14M 0.4% 94
2018
Q4
$16.7M Buy
336,671
+6,507
+2% +$391K 0.61% 53
2018
Q3
$23.4M Sell
330,164
-3,720
-1% -$237K 0.84% 35
2018
Q2
$17.4M Sell
333,884
-16,405
-5% -$859K 0.63% 63
2018
Q1
$18.3M Buy
350,289
+177,950
+103% +$9.02M 0.71% 51
2017
Q4
$10.1M Buy
+172,339
New +$9.77M 0.4% 91

Other funds holding NUVA

Rice Hall James & Associates's NUVA Position: Q1 2022 in Review

Rice Hall James & Associates sold out of NuVasive, Inc. (NUVA) in Q1 2022, closing a stake of 55,296 shares — an estimated $2.9M sold.

Rice Hall James & Associates first reported a position in NUVA in Q4 2017 and held it in 17 quarters. The position peaked at $23.4M in Q3 2018. 245 funds tracked by Wall St. Rank hold NUVA as of Q1 2022.

  • Rice Hall James & Associates reported no remaining NuVasive, Inc. position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 55,296 NuVasive, Inc. shares in Q1 2022, an estimated $2.9M.
  • Rice Hall James & Associates first reported a position in NuVasive, Inc. in Q4 2017 and held it in 17 quarters.
  • Rice Hall James & Associates's NuVasive, Inc. position peaked at $23.4M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.